Wellington Management

Wellington Management focuses on investment management by applying its full resources to meet the needs of institutional clients they serve.

Business Model:

Revenue: $1B

Employees: 501-1,000

Rankings

Detailed Wellington Management Information

Geographic Data

Wellington Management headquarters map

Address: 280 Congress Street

City: Boston

State: MA

Zip: 02210

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$2B

Metrics

397,658Website Global Rank

133,802Website Monthly Traffic

Twitter Followers

Description

Wellington Management focuses on investment management. The company applies its full resources to meet the needs of the institutional clients they serve. Their investment approaches span the global equity, fixed income, currency, commodity, and alternatives markets. They also offer asset allocation, multi-manager, and specialty approaches. It was founded in 1928 and headquartered in Boston, Massachusetts.

Contact Phone:
+16179515000

Contact Email:

Announced Date Company Transaction Money Raised
10/2020 Lordstown Motors Post-IPO Equity 500M
6/2022 FalconX Series D 0
2/2014 nCino Series B 11M
4/2015 Jounce Therapeutics Series B 0
1/2022 CodeSee Seed 7M
12/2021 JUSPAY Series C 60M
7/2017 WeWork China Series A 0
8/2018 Slack Series H 427M
1/2022 Creditas Series F 0
10/2014 Fintiv Series B 185M
4/2014 Pure Storage Series F 225M
6/2017 Nightstar Therapeutics Series C 45M
12/2019 Impulse Dynamics Series D 0
3/2015 Zuora Series F 0
6/2021 Payoneer PIPE 300M
9/2018 Atreca Series C 125M
11/2021 Faire Series G 0
3/2021 Zenas BioPharma Series A -
8/2016 Compass Series D 75M
8/2017 Atreca Series B 35M
10/2009 neoSaej Venture Round 1.7M
3/2020 Nurix Therapeutics Private Equity Round 120M
6/2021 Perella Weinberg Partners Post-IPO Equity 125M
8/2021 Trove Series D 77.5M
4/2014 Apigee Venture Round 0
6/2022 Kinside Series A 0
1/2021 Verve Therapeutics Series B 94M
10/2020 LianBio Series A 0
2/2015 Invuity Equity 22.9M
7/2020 Olema Oncology Series B 54M
2/2021 Gemini Therapeutics Post-IPO Equity 0
12/2019 Black Diamond Therapeutics Series C 0
3/2022 Span.IO Series B 0
11/2017 HeartFlow Series E 0
6/2020 Freeline Series C 80M
12/2020 Edgewise Therapeutics Series C 95M
11/2014 Powa Series C 80M
4/2023 HeartFlow Series F 0
12/2022 Dataiku Series F 200M
3/2023 CARGO Therapeutics Series A 0
1/2017 Neon Therapeutics Series B 70M
6/2017 Houzz Series E 400M
5/2021 NiKang Therapeutics Series C 200M
9/2020 Novellus Series C 57M
8/2020 PMV Pharmaceuticals Series D 70M
5/2014 Datalogix Series C 45M
7/2022 Meati Foods Series C 0
6/2021 Lendbuzz Series C 0
3/2021 Scribe Therapeutics Series B 100M
3/2020 JUSPAY Series B 21.6M
6/2019 Omada Health Series D 73M
9/2016 DEFY Media Series B 70M
4/2021 Urban Company Series F 188M
6/2015 Cogent Biosciences Series B 65M
3/2021 Paidy Series D 0
2/2016 Magic Leap Series C 793.5M
4/2021 Swiggy Series J 0
11/2017 Tricida Series D 0
1/2021 Affinivax Series C 226M
4/2019 Prove (formerly Payfone) Series G 15.1M
9/2022 RayzeBio Series D 160M
11/2021 Chroma Medicine Series A 125M
9/2020 Affirm Series G 500M
4/2015 Rethink Robotics Series D 13.4M
9/2014 Adaptimmune Series A 0
1/2015 Global Blood Therapeutics Series B 48M
9/2020 ESCAPE Bio Venture Round 73M
10/2021 BetterUp Series E 0
8/2015 Payoneer Series E 50M
4/2021 Current Series D 220M
7/2021 Blackbuck Series E 0
5/2017 Peloton Series E 0
8/2014 The Honest Company Series C 70M
9/2021 SpotOn Series E 300M
9/2021 Ventyx Biosciences Series B 0
3/2015 Birst Series F 65M
3/2021 Entrada Therapeutics Series B 0
5/2015 MarkLogic Series F 102M
7/2000 SensAble Technologies Series C 23M
9/2021 Asher Bio Series B 0
10/2020 Gracell Biotechnologies Series C 0
10/2019 Current Series B 31.2M
1/2015 Moderna Therapeutics Series E 0
8/2020 Synthego Series D 100M
12/2020 Cityblock Health Series C 160M
4/2019 Satsuma Pharmaceuticals Series B 0
6/2018 ezCater Series D 100M
5/2023 Quince Series B 0
12/2021 ROKT Series E 325M
11/2022 AMP Robotics Series C 0
1/2020 Generation Bio Series C 110M
4/2021 Patreon Series F 155M
8/2014 Pure Storage Secondary Market 60M
9/2020 Attentive Series D 230M
3/2021 Cityblock Health Series C 192M
1/2022 Dave Post-IPO Equity 0
12/2014 Redfin Series G 71M
9/2020 Skillz Post-IPO Equity 0
9/2020 Patreon Series E 90M
2/2022 Synthego Series E 0
6/2020 Goldfinch Biopharma Series B 100M
4/2015 Warby Parker Series D 100M
11/2022 MBX Biosciences Series B 115M
2/2021 Nuvation Bio Post-IPO Equity 502M
9/2015 General Assembly Series D 70M
4/2021 Greenlight Series D 260M
3/2023 Span.IO Series B 0
7/2021 Markforged Post-IPO Equity 0
6/2015 Airbnb Series E 1.5B
2/2021 Butterfly Network Post-IPO Equity 175M
12/2022 Apogee Therapeutics Series B 0
10/2014 Invitae Series F 0
10/2018 Coinbase Series E 300M
6/2015 Harry&s;s Series C 97.5M
4/2019 Affirm Series F 300M
9/2015 Rubicon Series C 57.1M
6/2021 Latch Post-IPO Equity 190M
6/2021 Faire Series F 260M
4/2019 ezCater Series D 150M
8/2014 Civitas Therapeutics Series C 0
11/2014 Nivalis Therapeutics Venture Round 30M
11/2021 Acrivon Therapeutics Series B 0
10/2020 Scopely Series E 340M
4/2023 Clerkie Series A 0
5/2015 DocuSign Series F 0
6/2015 TabbedOut Series C 21.5M
2/2021 Artiva Biotherapeutics Series B 120M
11/2022 Zenas BioPharma Series B 0
6/2023 Upstream Bio Series B 0
3/2020 Kymera Therapeutics Series C 102M
8/2015 Rhythm Metabolic Series A 40M
9/2021 Arcadia Series D 0
6/2014 Uber Series D 1.4B
1/2015 SoFi Series D 213M
6/2022 Guild Education Series F 0
10/2017 Forty Seven Series B 75M
2/2017 Fuze, an 8x8 company Series E 104M
9/2018 PagerDuty Series D 90M
8/2014 Lookout Series F 150M
6/2020 Prove (formerly Payfone) Series H 98M
11/2017 Compass Series E 0
5/2021 Snapdocs Series D 150M
12/2021 Anchorage Digital Series D 0
11/2019 ACV Series E 150M
2/2022 Somatus Series E 0
8/2018 Peloton Series F 0
5/2021 Nuvalent Series B 0
9/2020 Fore Biotherapeutics Series C 57M
3/2021 Ventyx Biosciences Series A 0
1/2021 Design Therapeutics Series B 125M
6/2016 Mersana Therapeutics Series C 33M
2/2021 Centessa Pharmaceuticals Series A 250M
7/2020 VelosBio Series B 137M
1/2020 Aligos Therapeutics Series B 125M
1/2021 Scorpion Therapeutics Series B 162M
11/2014 Blueprint Medicines Series C 50M
4/2021 Boundless Bio Series B 105M
5/2023 Boundless Bio Series C 0
7/2021 Strata Oncology Series C 0
6/2015 CytomX Therapeutics Series D 70M
10/2017 PolicyBazaar Series E 77M
5/2022 Arcadia Series E 0
2/2015 nCino Series B 29M
3/2023 Chroma Medicine Series B 0
2/2020 Swiggy Series I 113M
9/2015 SoFi Series E 1B
6/2023 Caraway Series A 0
3/2016 The Trade Desk Series C 60M
1/2016 ForeScout Technologies Series G 80M
3/2015 Nanigans Series B 24M
5/2016 Speakaboos Series B 12.5M
9/2021 Archaea Energy Post-IPO Equity 0
8/2020 Dyne Therapeutics Series B 115M
7/2022 Moving Analytics Series A 0
8/2013 Powa Series A 76M
1/2021 Billtrust Post-IPO Equity 200M
12/2014 Coupang Private Equity Round 300M
7/2021 Hyzon Motors Post-IPO Equity 0
1/2022 Digit Insurance Venture Round 70M
12/2020 Creditas Series E 255M
4/2014 New Relic Private Equity Round 100M
3/2021 Arrival Post-IPO Equity 400M
5/2019 Away Series D 100M
4/2021 Greenlight Series D 260M
8/2014 Nutanix Series E 140M
6/2021 ironSource Post-IPO Equity 0
10/2014 GreenSky Private Equity Round 350M
7/2016 Sprinklr Series F 105M
10/2020 Olema Oncology Series C 85M
4/2016 Kala Pharmaceuticals Series C 68M
10/2014 WeWork Series D 355M
12/2020 Porch Group Post-IPO Equity 150M
4/2021 Scale AI Series E 325M
11/2020 Current Series C 131M
8/2022 SeatGeek Series E 238M
5/2015 Pinterest Series G 186M
12/2022 ROKT Secondary Market -
7/2021 Thriveworks Venture Round -
10/2018 Tanium Private Equity Round 200M
12/2017 Neon Therapeutics Series B 36M
2/2022 Omada Health Series E 0
1/2021 PPRO Private Equity Round 180M
5/2021 Oxford Nanopore Technologies Venture Round 270.8M
8/2015 The Honest Company Series D 100M
12/2019 FORMA Therapeutics Series D 100M
9/2014 Veracode Series F 40M
7/2021 Sundae Series C 0
5/2016 BEGiN Series B 0
5/2014 Malauzai Software Series C 6.5M
11/2017 Arcus Biosciences Series C 107M
3/2015 Dataminr Series D 130M
12/2021 Course Hero Series C 380M
12/2021 Olist Series E 186M
4/2015 Sharecare Venture Round 0
7/2021 Lucid Motors Post-IPO Equity 0
7/2021 EVgo Post-IPO Equity 400M
8/2015 Klarna Secondary Market 80M
5/2014 Spark Therapeutics Series B 72.8M
12/2015 Allena Pharmaceuticals Series C 0
10/2022 immatics biotechnologies Post-IPO Equity 0
9/2022 flavrs Seed Round 0
4/2000 Optical Switch Venture Round 0
4/2015 Voyager Therapeutics Series B 0
4/2015 Oscar Health Series C 145M
11/2018 Auris Health Series E 0
12/2018 Swiggy Series H 1B
7/2017 Vets First Choice Private Equity Round 223M
6/2020 Verve Therapeutics Series A 63M
7/2022 Meati Foods Series C 0
7/2022 Moving Analytics Series A 0
6/2022 FalconX Series D 0
6/2022 Kinside Series A 0
6/2022 Guild Education Series F 0
5/2022 Arcadia Series E 0
3/2022 Span.IO Series B 0
2/2022 Omada Health Series E 0
2/2022 Somatus Series E 0
2/2022 Synthego Series E 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.